Blood & Tissue Collection Centers

Guidance

• FDA – Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components (July , 2018)Cdc-pdf[PDF – 18 pages]External
• FDA – Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products (Updated May 2018) Cdc-pdf[PDF – 12 pages]External

Additional Resources

• Zika Virus Response Updates from FDAExternal
• Cost Projections for Implementation of Safety Interventions to Prevent Transfusion-Transmitted Zika Virus Infection in the United StatesExternal
• Investigation Toolkit: Transfusion-transmitted Infections (TTI)
• Investigation Toolkit:  Transplant-Transmitted Infection
• MMWR: Screening of Blood Donations for Zika Virus Infection — Puerto Rico, April 3–June 11, 2016
• MMWR: Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection – Puerto Rico, 2016
• AABB – American Association of Blood BanksExternal
• Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April—August 2016 (EID)
• Companion Studies to Define the Distribution and Duration of Zika Virus Infection in Non-Human PrimatesExternal

CDC is working with our partners to learn more about Zika and blood/tissue safety

• AABB – American Association of Blood BanksExternal
• FDA – US Food and Drug AdministrationExternal
• State and territorial health departments
• Blood collection centers
• HCT/P industry